In utero stem cell transplants may replace riskier childhood transplants for multiple conditions – Medical Xpress
Medical Xpress |
In utero stem cell transplants may replace riskier childhood transplants for multiple conditions
Medical Xpress Tippi MacKenzie, MD, a pediatric and fetal surgeon at UCSF Benioff Children’s Hospital San Francisco, is the principal investigator for a clinical trial that will use in utero stem cell transplants to treat fetuses with an inherited disorder that … |
Scientific American |
Human Stem Cells Fight Parkinson’s Disease in Monkeys
Scientific American LONDON (Reuters)—Scientists have successfully used “reprogrammed” stem cells to restore functioning brain cells in monkeys, raising hopes the technique could be used in future to help patients with Parkinson’s disease. Since Parkinson’s is caused by a … Parkinson’s: Stem cells restore nerve function in monkeysMedical News Today Scientists are ready to treat Parkinson’s with stem cells — QuartzQuartz Trials to inject stem cells into brains of Parkinson’s patients could begin next yearTelegraph.co.uk Nature.com –The Times –The Independent all 28 news articles » |
South China Morning Post |
US approves ‘breakthough’ gene therapy for leukaemia
South China Morning Post The US approved the first gene therapy against cancer on Wednesday – a treatment that uses a patient’s own immune cells to fight leukaemia – opening a new era in the fight against one of the world’s top killers. The treatment is made by Novartis and is … FDA Approves Groundbreaking Gene Therapy for CancerMIT Technology Review FDA approval brings first gene therapy to the United StatesFDA.gov FDA Approves First Gene Therapy For LeukemiaNPR CNN –National Cancer Institute all 656 news articles » |
|
Editas Medicine, Inc. (NASDAQ:EDIT) Stock Closed Much Higher …
Finance Daily Company shares last traded at $21.26 significantly higher than $17.75, the stock’s 50 day moving average and well above the 200 day moving average of … |